# 119-hr-9192: Prior Authorization Reform for Autoimmune and Blood Disorders Act

119-hr-9192, Prior Authorization Reform for Autoimmune and Blood Disorders Act, is a 119th Congress bill sponsored by Rep. Johnson, Julie [D-TX-32] (D-TX); status introduced; PRIA reads it as touching household money (as of 2026-10-17).

- Canonical: https://policyrisk.com/legislation/119-hr-9192
- As of: 2026-10-17
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-9192
- Congress: 119
- Title: Prior Authorization Reform for Autoimmune and Blood Disorders Act
- Status: introduced
- Introduced: 2026-06-08
- Sponsor: Rep. Johnson, Julie [D-TX-32] (D-TX)
- Cosponsors: 2
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-10-17

## Summary

**Creates uniform coverage and limits prior authorization for autoimmune and certain blood disorder drugs across employer plans, private insurers, and tax-advantaged health arrangements.** It would require plans and insurers to cover any drug prescribed for autoimmune disease, hemophilia, or Von Willebrand disease regardless of whether the drug is dispensed at a pharmacy or furnished with another service. Prior authorization could not be required more than once in any 12-month period unless the drug is typically used for 12 months or less, is an opioid, benzodiazepine, barbiturate, or carisoprodol, or is subject to an FDA risk evaluation and mitigation strategy (REMS). - Workers and employer-sponsored plans: Under the ERISA track, group health plans must cover these drugs regardless of dispensing location and generally may not require prior authorization more than once each 12 months except for the listed exceptions. - People with private individual and group coverage: The Public Health Service Act track imposes the same coverage and prior-authorization rules on health insurance issuers offering group and individual policies. - Tax-preferred plans and timing: The Internal Revenue Code track extends the rules to tax-advantaged group health plans and applies to plan years beginning on or after January 1, 2027.

## Cosponsors (2)

- Rep. Bresnahan, Robert P. [R-PA-8] (R-PA), 2026-10-15T00:00:00.000Z
- Rep. Lawler, Michael [R-NY-17] (R-NY), 2026-06-08T00:00:00.000Z

## Provisions PRIA read

- Fewer prior authorizations for autoimmune patients: benefit, high. If enacted, the bill would require group health plans, health insurers that sell group or individual coverage, and employer tax-advantaged plans to cover drugs for autoimmune diseases, hemophilia, and Von Willebrand disease regardless of where the drug is dispensed. Plans and issuers would not be a…

## Related bills

- 119-hr-6900: American Affordability Act of 2025
- 119-hr-3151: SHIPS for America Act of 2025
- 119-hr-9237: Take Care of America’s Veterans Act
- 119-hr-4317: PBM Reform Act of 2025
- 119-hr-6644: 21st Century ROAD to Housing Act
- 119-hr-1229: United States-Israel Defense Partnership Act of 2025

## Sources
- [119-hr-9192 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/9192)

## Related
- [119-hr-6900: American Affordability Act of 2025](https://policyrisk.com/legislation/119-hr-6900)
- [119-hr-3151: SHIPS for America Act of 2025](https://policyrisk.com/legislation/119-hr-3151)
- [119-hr-9237: Take Care of America’s Veterans Act](https://policyrisk.com/legislation/119-hr-9237)
- [119-hr-4317: PBM Reform Act of 2025](https://policyrisk.com/legislation/119-hr-4317)
- [119-hr-6644: 21st Century ROAD to Housing Act](https://policyrisk.com/legislation/119-hr-6644)
- [119-hr-1229: United States-Israel Defense Partnership Act of 2025](https://policyrisk.com/legislation/119-hr-1229)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-9192 (as of 2026-10-17).